Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CYNODON DACTYLON POLLEN vs DABRAFENIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CYNODON DACTYLON POLLEN vs DABRAFENIB: Safety Overview

Metric CYNODON DACTYLON POLLEN DABRAFENIB
Total FAERS Reports 164 19,305
Deaths Reported 1 4,165
Death Rate 0.6% 21.6%
Hospitalizations 8 5,325
Average Patient Age 35.6 yrs 58.3 yrs
% Female Patients 62.1% 48.0%
FDA Approval Date N/A Mar 16, 2023
Manufacturer ALK-Abello, Inc. Novartis Pharmaceuticals Corporation
Route N/A ORAL
Marketing Status N/A Prescription